Dr. Stuart Bergman-Bock, MD

  • Minneapolis, MN
  • Neurologist
NPI1639463185PAC ID8426341249
Medicare services, 2024
557
Medicare patients, 2024
273
Part D claims, 2024
1,847
Publications
2
MIPS score, 2024
92
Practice address
4225 Golden Valley Rd, Minneapolis, MN 55422
Practice phone
Call (763) 588-0661
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Minneapolis Clinic of Neurology, Ltd

Minneapolis, Minnesota

See all 7 affiliations

Find Dr. Bergman-Bock's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Stuart Bergman-Bock is a neurologist in Minneapolis, Minnesota

Dr. Bergman-Bock practices at Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota.

Dr. Bergman-Bock's NPI, 1639463185, was assigned on June 1, 2011. Dr. Bergman-Bock graduated from University of Louisville School of Medicine in 2011. Dr. Bergman-Bock holds Minnesota license 66213.

NPI and contact details
Medicare PAC ID
8426341249
NPI enumeration date
June 1, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(763) 588-0661
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Stuart Bergman-Bock practices at Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota

Dr. Bergman-Bock's primary practice is Minneapolis Clinic of Neurology, Ltd, at 4225 Golden Valley Rd, Minneapolis, MN 55422 in Hennepin County. The practice phone is (763) 588-0661.

  • Minneapolis Clinic of Neurology, Ltd
    4225 Golden Valley Rd, Minneapolis, MN 55422 · Hennepin CountyPhone(763) 588-0661

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Stuart Bergman-Bock is affiliated with 6 sites of care and 1 medical group

Dr. Bergman-Bock's primary practice is Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota. Dr. Bergman-Bock is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is Minneapolis Clinic of Neurology. Dmand AI also links Dr. Bergman-Bock to 3 more hospitals and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Bergman-Bock

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Stuart Bergman-Bock's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergman-Bock practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Minneapolis Clinic of Neurology, LtdAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bergman-Bock practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Stuart Bergman-Bock is one of 499 neurologists in Minnesota

Neurology is Dr. Bergman-Bock's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bergman-Bock is licensed in Minnesota.

Specialties and state licenses

  • Neurology, MinnesotaPrimaryLicense 66213 · taxonomy 2084N0400X

Neurologists near Dr. Bergman-Bock

Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Stuart Bergman-Bock billed Medicare for 557 services in 2024

CMS data shows 557 Medicare services from Dr. Bergman-Bock across 12 procedure codes in 2024, for 273 Medicare patients. Medicare paid $44,223 for them.

Medicare services, 2024557
Medicare patients273
Paid by Medicare$44,223
Procedure codes12

Dr. Bergman-Bock's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2582024: 31522%
Other services
2023: 02024: 205
Imaging
2023: 512024: 3727%

Where Dr. Bergman-Bock's Medicare services took place, 2024

  • In an office50791%
  • In a facility509%

Dr. Bergman-Bock compared with the Minnesota median for neurologists, 2024

  • Dr. Bergman-Bock
  • Minnesota median
Medicare services
557vs 2532.2 times
Medicare patients
273vs 15082% above
Part D claims
1,605vs 12912.4 times

Medians across 462 neurologists in Minnesota with Dmand AI profiles that report each measure.

Dr. Bergman-Bock's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bergman-Bock

Need commercial claims for Dr. Bergman-Bock?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bergman-Bock and other neurologists in Minnesota.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Stuart Bergman-Bock treated 273 Medicare patients in 2024, average age 73

CMS counts 273 Medicare patients who saw Dr. Bergman-Bock in 2024. The largest group is 75 to 84, with 106 patients. 72% of them have high cholesterol, and 71% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bergman-Bock's median patient age at 68, with 63% women.

Medicare patients, 2024273
Average age73
Average risk score1.53
Also on Medicaid13%

Dr. Bergman-Bock's Medicare patients by age, 2024

Dr. Bergman-Bock's Medicare patients by sex, 2024

  • Women16761%
  • Men10639%

Chronic conditions among Dr. Bergman-Bock's Medicare patients, 2024

  1. High cholesterol72%
  2. High blood pressure71%
  3. Arthritis43%
  4. Mood disorders42%
  5. Depression40%
  6. Anxiety38%
  7. Ischemic heart disease29%
  8. Chronic kidney disease28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bergman-Bock's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women63%
  • Men37%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Stuart Bergman-Bock wrote 1,847 Medicare Part D claims in 2024

In 2024, Dr. Bergman-Bock wrote 1,847 Medicare Part D claims for 392 patients. 89% of them were for generic drugs. CMS names the drug for 1,605 of them, across 35 drugs with 11 or more claims each, at $180,141 in total drug cost. In 2023, CMS named 1,200 claims across 28 drugs.

Part D claims, 20241,847
Drugs named by CMS35
Total drug cost$180,141
Part D patients392

Dr. Bergman-Bock's Part D claims by kind of drug, 2024

  • Generic1,652 claims89%
  • Brand-name184 claims10%
  • Other11 claims1%

Dr. Bergman-Bock's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bergman-Bock's Part D claims, 2024

  • Antipsychotics, patients 65 and over2%28 of 1,847 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,2002024: 1,60534%

Drugs named by CMS: 35 in 2024, 28 in 2023.

See all prescribing by Dr. Bergman-Bock

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Stuart Bergman-Bock scored 92 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Bergman-Bock for performance year 2024, reported as part of a group. Dr. Bergman-Bock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bergman-Bock as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Bergman-Bock's MIPS scores, performance year 2024

  • 92of 100Final score
  • 84.1of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 84of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find neurologists like Dr. Bergman-Bock by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Stuart Bergman-Bock has 2 publications on record

Dmand AI links 2 papers to Dr. Bergman-Bock, published from 2018 to 2024. Dr. Bergman-Bock's most frequent co-authors are Tiffani Stroup Franada, DO, Thomas Freedom, MD and Angela N. Mark, MD.

Papers2
Years published2018 to 2024

Dr. Bergman-Bock's most frequent co-authors

Recent publications by Dr. Bergman-Bock

See all 2 publications and co-authors

See who Dr. Bergman-Bock researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bergman-Bock works with, so you can find a warm path to the right neurologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Stuart Bergman-Bock received $1,257 in industry payments from 2017 to 2025

CMS Open Payments shows 68 general payments to Dr. Bergman-Bock from 32 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $127.

General payments to Dr. Bergman-Bock by program year, 2017 to 2025

Companies that paid Dr. Bergman-Bock the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Bergman-Bock

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Stuart Bergman-Bock graduated from University of Louisville School of Medicine

Dr. Bergman-Bock graduated from University of Louisville School of Medicine in 2011.

  1. Medical schoolUniversity of Louisville School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Stuart Bergman-Bock's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Stuart Bergman-Bock

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Stuart Bergman-Bock's NPI number?

Dr. Stuart Bergman-Bock's NPI number is 1639463185. It was assigned on June 1, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Stuart Bergman-Bock?

Dr. Stuart Bergman-Bock is a neurologist in Minneapolis, Minnesota. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).

Where does Dr. Stuart Bergman-Bock practice?

Dr. Bergman-Bock practices at 4225 Golden Valley Rd, Minneapolis, MN 55422. Dr. Bergman-Bock's primary practice is Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota. Dmand AI also links Dr. Bergman-Bock to 3 hospitals and 1 group practice or clinic.

What is Dr. Stuart Bergman-Bock's office phone number?

The practice phone on file for Dr. Bergman-Bock is (763) 588-0661.

What is Dr. Stuart Bergman-Bock's medical license number?

Dr. Bergman-Bock holds Minnesota license 66213.

Which hospitals is Dr. Stuart Bergman-Bock affiliated with?

Dr. Bergman-Bock is affiliated with M Health Fairview Southdale Hospital. Dmand AI links Dr. Bergman-Bock to 3 more hospitals.

What medical group is Dr. Stuart Bergman-Bock part of?

Dr. Bergman-Bock is linked to Minneapolis Clinic of Neurology.

Does Dr. Stuart Bergman-Bock accept Medicare?

Yes. CMS data shows Dr. Bergman-Bock billed Medicare for 557 services in 2024, and Dr. Bergman-Bock accepts Medicare assignment.

Does Dr. Stuart Bergman-Bock offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Bergman-Bock as offering telehealth services.

What is Dr. Stuart Bergman-Bock's MIPS score?

Dr. Bergman-Bock's MIPS final score for performance year 2024 is 92 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Stuart Bergman-Bock see?

CMS counts 273 Medicare patients who saw Dr. Bergman-Bock in 2024, with an average age of 73.

What services does Dr. Stuart Bergman-Bock bill to Medicare?

In 2024, Dr. Bergman-Bock's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).

Where did Dr. Stuart Bergman-Bock go to medical school?

Dr. Bergman-Bock graduated from University of Louisville School of Medicine in 2011.

What drugs does Dr. Stuart Bergman-Bock prescribe most?

In 2024 Medicare Part D data, Dr. Bergman-Bock's most prescribed drugs by claims were Donepezil HCl, Carbidopa-Levodopa and Gabapentin.

Has Dr. Stuart Bergman-Bock received payments from drug or device companies?

CMS Open Payments shows $1,257 in general payments to Dr. Bergman-Bock from 32 companies from 2017 to 2025. The largest total came from Amgen Inc.

How long has Dr. Stuart Bergman-Bock been practicing?

Dr. Bergman-Bock graduated from medical school in 2011, 15 years ago.

Does Dr. Stuart Bergman-Bock do research?

Dmand AI links 2 publications to Dr. Bergman-Bock, published from 2018 to 2024.

Who does Dr. Stuart Bergman-Bock publish with?

Dr. Bergman-Bock's most frequent co-authors are Tiffani Stroup Franada, DO (2 shared papers), Thomas Freedom, MD (2 shared papers) and Angela N. Mark, MD (2 shared papers).

Selling to neurology practices?

See neurologists in Minnesota by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)